These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9671702)

  • 1. Synergy between simulation and experiment in describing the energy landscape of protein folding.
    Ladurner AG; Itzhaki LS; Daggett V; Fersht AR
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8473-8. PubMed ID: 9671702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding.
    Pan Y; Daggett V
    Biochemistry; 2001 Mar; 40(9):2723-31. PubMed ID: 11258883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism.
    Neira JL; Davis B; Ladurner AG; Buckle AM; Gay Gde P; Fersht AR
    Fold Des; 1996; 1(3):189-208. PubMed ID: 9079381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the transition state for folding of a protein derived from experiment and simulation.
    Daggett V; Li A; Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1996 Mar; 257(2):430-40. PubMed ID: 8609634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of protein-unfolding transition states identified in molecular dynamics simulations.
    Daggett V
    Biochem Soc Symp; 2001; (68):83-93. PubMed ID: 11573349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein folding from a highly disordered denatured state: the folding pathway of chymotrypsin inhibitor 2 at atomic resolution.
    Kazmirski SL; Wong KB; Freund SM; Tan YJ; Fersht AR; Daggett V
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4349-54. PubMed ID: 11274353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of two-state to multi-state folding kinetics on fusion of two protein foldons.
    Inaba K; Kobayashi N; Fersht AR
    J Mol Biol; 2000 Sep; 302(1):219-33. PubMed ID: 10964571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding of circular and permuted chymotrypsin inhibitor 2: retention of the folding nucleus.
    Otzen DE; Fersht AR
    Biochemistry; 1998 Jun; 37(22):8139-46. PubMed ID: 9609709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the unfolding transition state of chymotrypsin inhibitor 2 by molecular dynamics simulations.
    Li A; Daggett V
    J Mol Biol; 1996 Mar; 257(2):412-29. PubMed ID: 8609633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Energy Channeling and Malleable Transition States: Molecular Dynamics Simulations and Free Energy Landscapes for the Thermal Unfolding of Protein U1A and 13 Mutants.
    Dang NL; Baranger AM; Beveridge DL
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory.
    Finke JM; Cheung MS; Onuchic JN
    Biophys J; 2004 Sep; 87(3):1900-18. PubMed ID: 15345567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer simulations of protein folding by targeted molecular dynamics.
    Ferrara P; Apostolakis J; Caflisch A
    Proteins; 2000 May; 39(3):252-60. PubMed ID: 10737947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications.
    Fersht AR
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10869-73. PubMed ID: 7479900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the hydrophobic core in the transition state for folding of chymotrypsin inhibitor 2: a critical test of the protein engineering method of analysis.
    Jackson SE; elMasry N; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11270-8. PubMed ID: 8218192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "New view" of protein folding reconciled with the old through multiple unfolding simulations.
    Lazaridis T; Karplus M
    Science; 1997 Dec; 278(5345):1928-31. PubMed ID: 9395391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the major transition state for folding of an FF domain from experiment and simulation.
    Jemth P; Day R; Gianni S; Khan F; Allen M; Daggett V; Fersht AR
    J Mol Biol; 2005 Jul; 350(2):363-78. PubMed ID: 15935381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the folding/unfolding transition state ensemble of chymotrypsin inhibitor 2 to changes in temperature and solvent.
    Day R; Daggett V
    Protein Sci; 2005 May; 14(5):1242-52. PubMed ID: 15840831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain in the folding nucleus of chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; Fersht AR
    Fold Des; 1997; 2(6):363-8. PubMed ID: 9427010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.